Next Article in Journal
Preparation of Xanthene-TEMPO Dyads: Synthesis and Study of the Radical Enhanced Intersystem Crossing
Next Article in Special Issue
Humanized NSG Mouse Models as a Preclinical Tool for Translational Research in Inflammatory Bowel Diseases
Previous Article in Journal
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
Previous Article in Special Issue
CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 13
10.3390/ijms241311217
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease

by
Vibeke Andersen
1,2,*,
Tue B. Bennike
1,3,
Corinna Bang
4,
John D. Rioux
5,6,
Isabelle Hébert-Milette
5,6,
Toshiro Sato
7,
Axel K. Hansen
8 and
Ole H. Nielsen
9,*
1
Molecular Diagnostic and Clinical Research Unit, University Hospital of Southern Denmark, Institute of Regional Research, University of Southern Denmark, 5000 Odense, Denmark
2
Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark
3
Medical Microbiology and Immunology, Department of Health Science and Technology, Aalborg University, 9000 Aalborg, Denmark
4
Institute for Clinical Molecular Biology, Christian-Albrecht’s University, 24105 Kiel, Germany
5
Department of Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada
6
Montreal Heart Institute Research Institute, Montreal, QC H1T 1C8, Canada
7
Department of Gastroenterology, Keio University School of Medicine, Tokyo 160-8582, Japan
8
Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark
9
Department of Gastroenterology, Herlev Hospital, University of Copenhagen, 2730 Herlev, Denmark
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(13), 11217; https://doi.org/10.3390/ijms241311217
Submission received: 31 May 2023 / Revised: 23 June 2023 / Accepted: 26 June 2023 / Published: 7 July 2023
(This article belongs to the Special Issue Inflammatory Bowel Disease: From Pre-clinial Models into Translation)
Browse Figures
Review Reports Versions Notes

Abstract

Inflammatory bowel diseases (IBD) are without cure and troublesome to manage because of the considerable diversity between patients and the lack of reliable biomarkers. Several studies have demonstrated that diet, gut microbiota, genetics and other patient factors are essential for disease occurrence and progression. Understanding the link between these factors is crucial for identifying molecular signatures that identify biomarkers to advance the management of IBD. Recent technological breakthroughs and data integration have fuelled the intensity of this research. This research demonstrates that the effect of diet depends on patient factors and gut microbial activity. It also identifies a range of potential biomarkers for IBD management, including mucosa-derived cytokines, gasdermins and neutrophil extracellular traps, all of which need further evaluation before clinical translation. This review provides an update on cutting-edge research in IBD that aims to improve disease management and patient quality of life.
Keywords: biomarkers; Crohn’s disease; gut microbiota; intestinal barrier; personalised medicine; ulcerative colitis biomarkers; Crohn’s disease; gut microbiota; intestinal barrier; personalised medicine; ulcerative colitis

Share and Cite

MDPI and ACS Style

Andersen, V.; Bennike, T.B.; Bang, C.; Rioux, J.D.; Hébert-Milette, I.; Sato, T.; Hansen, A.K.; Nielsen, O.H. Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease. Int. J. Mol. Sci. 2023, 24, 11217. https://doi.org/10.3390/ijms241311217

AMA Style

Andersen V, Bennike TB, Bang C, Rioux JD, Hébert-Milette I, Sato T, Hansen AK, Nielsen OH. Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2023; 24(13):11217. https://doi.org/10.3390/ijms241311217

Chicago/Turabian Style

Andersen, Vibeke, Tue B. Bennike, Corinna Bang, John D. Rioux, Isabelle Hébert-Milette, Toshiro Sato, Axel K. Hansen, and Ole H. Nielsen. 2023. "Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease" International Journal of Molecular Sciences 24, no. 13: 11217. https://doi.org/10.3390/ijms241311217

APA Style

Andersen, V., Bennike, T. B., Bang, C., Rioux, J. D., Hébert-Milette, I., Sato, T., Hansen, A. K., & Nielsen, O. H. (2023). Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease. International Journal of Molecular Sciences, 24(13), 11217. https://doi.org/10.3390/ijms241311217

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop